Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Novozymes A/S (NVZMY) Stock-Based Compensation data is not available.
| Income Statement Financials | |
$1.14B |
|
$195.95M |
|
$509.16M |
|
$626.10M |
|
$855.55M |
|
$279.70M |
|
$-21.91M |
|
$257.79M |
|
$257.79M |
|
$195.95M |
|
$195.95M |
|
$195.95M |
|
$195.95M |
|
$279.70M |
|
$279.70M |
|
465.00M |
|
465.00M |
|
$0.42 |
|
$0.42 |
|
| Balance Sheet Financials | |
$2.05B |
|
$3.07B |
|
$13.81B |
|
$15.86B |
|
$1.23B |
|
$1.34B |
|
$2.80B |
|
$4.03B |
|
$11.83B |
|
$1.43B |
|
$11.83B |
|
-- |
|
| Cash Flow Statement Financials | |
$112.09M |
|
$-40.35M |
|
$-107.56M |
|
$294.98M |
|
$262.85M |
|
$-32.13M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
0.10 |
|
0.15 |
|
55.15% |
|
24.64% |
|
24.64% |
|
-- |
|
22.71% |
|
17.26% |
|
$82.07M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.66 |
|
1.14 |
|
79.24 |
|
1.66% |
|
13.74% |
|
1.24% |
|
1.49% |
|
-- |
|
$0.18 |
|
$0.24 |
|